Protagonist Therapeutics, Inc ($PTGX)
Filing Information
| Accession Number | 0001104659-26-036317 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 27, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
74,295
Total Value
$3,019,783.65
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Mar 26, 2026 | Exercise/Conversion | 19,500 | $19.19 | $374,205.00 | 80,253 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 26, 2026 | Exercise/Conversion | 5,265 | $12.17 | $64,075.05 | 85,518 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 26, 2026 | Sale | 24,765 | $104.24 | $2,581,503.60 | 60,753 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (right to buy) | Derivative | Mar 26, 2026 | Exercise/Conversion | 19,500 | $0.00 | $0.00 | 31,300 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (right to buy) | Derivative | Mar 26, 2026 | Exercise/Conversion | 5,265 | $0.00 | $0.00 | 13,282 | Direct | โ | View Details |